Therapeutics: Complement component 3a receptor 1 (C3AR1; C3AR); NF-κB; complement 3 (C3)

Neurology

INDICATION: Alzheimer's disease (AD)

In vitro and mouse studies suggest antagonizing C3AR could help

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE